Standout Papers

A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis 2003 2026 2010 2018 933
  1. A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis (2003)
    David H. Miller, Omar Khan et al. New England Journal of Medicine

Immediate Impact

2 by Nobel laureates 27 from Science/Nature 81 standout
Sub-graph 1 of 18

Citing Papers

Physiology and diseases of tissue-resident macrophages
2023 StandoutNature
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis
2021 StandoutScienceNobel
14 intermediate papers

Works of Omar Khan being referenced

A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
2003 Standout

Author Peers

Author Last Decade Papers Cites
Omar Khan 2073 935 895 86 3.8k
Walter Hader 2113 497 1238 101 5.3k
John R. Corboy 2247 517 1118 108 3.8k
Jeremy Chataway 2551 519 1034 165 4.9k
Stephen Lake 2051 780 770 63 5.5k
Giulio Disanto 3268 757 1237 92 5.2k
David Laplaud 1917 578 961 117 4.0k
D. P. E. Kingsley 2066 486 1552 84 4.7k
Harald Nyland 3371 481 1543 172 6.4k
H. Carton 1305 493 626 103 4.1k
Oluf Andersen 2528 773 1462 135 5.8k

All Works

Loading papers...

Rankless by CCL
2026